13:06:04 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-03-12 Årsstämma 2025
2025-02-05 Bokslutskommuniké 2024
2024-10-22 Kvartalsrapport 2024-Q3
2024-07-23 Kvartalsrapport 2024-Q2
2024-04-23 Kvartalsrapport 2024-Q1
2024-03-13 Ordinarie utdelning EMBLA 0.00 DKK
2024-03-13 Årsstämma 2024
2024-03-12 Årsstämma 2024
2024-01-30 Bokslutskommuniké 2023
2023-10-24 Kvartalsrapport 2023-Q3
2023-07-25 Kvartalsrapport 2023-Q2
2023-04-25 Kvartalsrapport 2023-Q1
2023-03-13 Ordinarie utdelning EMBLA 0.00 DKK
2023-03-10 Årsstämma 2023
2023-01-31 Bokslutskommuniké 2022
2022-10-25 Kvartalsrapport 2022-Q3
2022-07-21 Kvartalsrapport 2022-Q2
2022-04-26 Kvartalsrapport 2022-Q1
2022-03-09 Ordinarie utdelning EMBLA 0.00 DKK
2022-03-08 Årsstämma 2022
2022-02-01 Bokslutskommuniké 2021
2021-10-26 Kvartalsrapport 2021-Q3
2021-07-22 Kvartalsrapport 2021-Q2
2021-04-27 Kvartalsrapport 2021-Q1
2021-03-09 Ordinarie utdelning EMBLA 0.00 DKK
2021-03-08 Årsstämma 2021
2021-02-02 Bokslutskommuniké 2020
2020-10-27 Kvartalsrapport 2020-Q3
2020-07-23 Kvartalsrapport 2020-Q2
2020-04-30 Kvartalsrapport 2020-Q1
2020-03-13 Ordinarie utdelning EMBLA 0.15 DKK
2020-03-12 Årsstämma 2020
2020-02-04 Bokslutskommuniké 2019
2019-10-22 Kvartalsrapport 2019-Q3
2019-07-25 Kvartalsrapport 2019-Q2
2019-04-30 Kvartalsrapport 2019-Q1
2019-03-08 Ordinarie utdelning EMBLA 0.14 DKK
2019-03-07 Årsstämma 2019
2019-02-05 Bokslutskommuniké 2018
2018-10-24 Kvartalsrapport 2018-Q3
2018-07-25 Kvartalsrapport 2018-Q2
2018-04-25 Kvartalsrapport 2018-Q1
2018-03-09 Ordinarie utdelning EMBLA 0.13 DKK
2018-03-08 Årsstämma 2018
2018-02-05 Bokslutskommuniké 2017
2017-10-24 Kvartalsrapport 2017-Q3
2017-07-25 Kvartalsrapport 2017-Q2
2017-04-27 Kvartalsrapport 2017-Q1
2017-03-10 Ordinarie utdelning EMBLA 0.12 DKK
2016-03-11 Ordinarie utdelning EMBLA 0.12 DKK
2016-03-10 Årsstämma 2016
2016-02-02 Bokslutskommuniké 2015
2015-10-22 Kvartalsrapport 2015-Q3
2015-07-23 Kvartalsrapport 2015-Q2
2015-04-29 Kvartalsrapport 2015-Q1
2015-03-12 Årsstämma 2015
2015-02-05 Bokslutskommuniké 2014
2014-10-24 Analytiker möte 2014
2014-10-23 Kvartalsrapport 2014-Q3
2014-07-25 Analytiker möte 2014
2014-07-24 Kvartalsrapport 2014-Q2
2014-04-30 Analytiker möte 2014
2014-04-29 Kvartalsrapport 2014-Q1
2014-03-14 Årsstämma 2014
2014-02-05 Bokslutskommuniké 2013
2013-10-24 Analytiker möte 2013
2013-10-23 Kvartalsrapport 2013-Q3
2013-07-24 Kvartalsrapport 2013-Q2
2013-04-24 Kvartalsrapport 2013-Q1
2013-03-15 Årsstämma 2013
2013-02-06 Bokslutskommuniké 2012
2012-11-28 Kapitalmarknadsdag 2012
2012-11-27 Kapitalmarknadsdag 2012
2012-10-24 Analytiker möte 2012
2012-10-23 Kvartalsrapport 2012-Q3
2012-07-25 Kvartalsrapport 2012-Q2
2012-04-24 Kvartalsrapport 2012-Q1
2012-03-16 Årsstämma 2012
2012-02-08 Bokslutskommuniké 2011
2011-10-27 Kvartalsrapport 2011-Q3
2011-07-28 Kvartalsrapport 2011-Q2
2011-03-04 Årsstämma 2011

Beskrivning

LandIsland
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriMedicinteknik
Össur hf. är ett isländskt bolag verksamma inom hälsa - och sjukvård. Idag innehas affärsinriktning mot utvecklandet av benproteser, artros samt relaterad skadehantering. Produkterna är anpassade för olika åldrar och förutsättningar beroende på patientens svårighetsgrad. Verksamheten är etablerad globalt med störst marknad inom Europa följt av Nordamerika. Huvudkontoret ligger i Reykjavik.
2020-04-07 17:15:48

7 April 2020 

Approval notice from FTC received regarding acquisition of College Park Industries

As announced on 19 July 2019, Össur had signed an agreement to acquire College Park Industries (CPI), a global provider of prosthetic devices and supporting services headquartered in Michigan, USA. Closing of the transaction was subject to certain closing conditions including regulatory review.

Today, Össur received approval notice from the United States Federal Trade Commission (FTC) regarding the acquisition of CPI, conditioned on divestiture of CPI's bionic elbow business, sold under the Espire brand. Consequently, UK-based global supplier of prosthetic devices and patient care services, Steeper Group, will take over the Espire portfolio, which was successfully launched by CPI about one year ago. CPI's pro-forma FY2019 sales excluding the Espire sales would amount to approximately USD 20 million.

Given the unprecedented uncertainty caused by the global COVID-19 pandemic, the parties have agreed to remain flexible on closing date with the intent to conclude their respective transactions within the next 3 months.

As previously communicated, CPI will largely remain independent and continue to diligently serve its customer base, while allowing the combined entity to achieve strategic efficiencies. Össur remains committed to growing the College Park brand globally over the coming years and supporting its focus on the lower active population. Mutual access to technology and products will enable a more comprehensive product and service offering to customers around the world.

Further information 

David Hreidarsson, Investor Relations, dhreidarsson@ossur.com,+354 661 8225

Helga Danielsdottir, Investor Relations, hdanielsdottir@ossur.com,+354 766 4959

Össur press releases by e-mail 

If you wish to receive Össur press releases by e-mail please register at http://www.ossur.com/investors

About Össur 

Össur (Nasdaq Copenhagen: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. A recognized "Technology Pioneer," Össur focuses on improving people's mobility through the delivery of innovative technologies in Prosthetics and Bracing & Supports, by investing significantly in research and product development to create award-winning designs with consistently strong market positions. Successful patient and clinical outcomes are further empowered via Össur's educational programs and business solutions.  As part of Össur's long-standing commitment to social responsibility, the company has been a signatory to the United Nations Global Compact since 2011, and participates in the Nasdaq Nordic and Baltic exchanges' voluntary guidelines for Environment, Social and Corporate Governance (ESG). Össur is headquartered in Iceland, with major operations in the Americas, Europe and Asia, and additional distributors worldwide. www.ossur.com

About College Park IndustriesCollege Park Industries is an established global provider of broad and competitive prosthetic solutions. It has been well recognized for providing a varied portfolio of prosthetic feet, with the Truestep and Odyssey lines becoming frequent solutions clinicians reach out for. With its 2015 acquisition of Liberating Technologies, College Park ventured into the upper limb arena with its first bionic product - the Espire Elbow launched in April 2019. College Park is the 2018 recipient of the Hanger Service Excellence Award, a demonstration of its continued commitment to deliver unsurpassed customer service alongside competitive products. To learn more, visit www.collegeparkindustries.com